These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identification and antifungal susceptibility of fungi isolated from dermatomycoses. Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501 [TBL] [Abstract][Full Text] [Related]
5. Tonui J; Mureithi M; Jaoko W; Bii C Pan Afr Med J; 2021; 38():227. PubMed ID: 34046132 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria. Kokjohn K; Bradley M; Griffiths B; Ghannoum M Int J Dermatol; 2003 Sep; 42 Suppl 1():11-7. PubMed ID: 12895182 [TBL] [Abstract][Full Text] [Related]
7. In vitro antifungal activity of Polyporaceae against yeasts and dermatophytes. Steinmetz MD; Rascol JP; Régli P; Gargadennec A; Andary C Mycoses; 1995; 38(7-8):305-9. PubMed ID: 8559195 [TBL] [Abstract][Full Text] [Related]
8. [In vitro action spectrum of a new antifungal agent derived from morpholine: amorolfin]. Regli P; Ferrari H Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):617-20. PubMed ID: 2797885 [TBL] [Abstract][Full Text] [Related]
9. [Increasing frequency of onychomycoses--is there a change in the spectrum of infectious agents?]. Ginter G; Rieger E; Heigl K; Propst E Mycoses; 1996; 39 Suppl 1():118-22. PubMed ID: 8767283 [TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents. Carrillo-Muñoz AJ; Quindós G; Del Valle O; Santos P; Giusiano G; Guardia C; Eraso E; Ezkurra PA; Tur-Tur C; Hernández-Molina JM J Chemother; 2008 Aug; 20(4):521-3. PubMed ID: 18676237 [No Abstract] [Full Text] [Related]
11. [In vitro spectrum of action of a new antifungal derivative of naftifin: terbinafin (SF 86-327)]. Goudard M; Buffard Y; Ferrari H; Regli P Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):680-3. PubMed ID: 3534767 [TBL] [Abstract][Full Text] [Related]
12. Value of the ethnomedical information for the discovery of plants with antifungal properties. A survey among seven Latin American countries. Svetaz L; Zuljan F; Derita M; Petenatti E; Tamayo G; Cáceres A; Cechinel Filho V; Giménez A; Pinzón R; Zacchino SA; Gupta M J Ethnopharmacol; 2010 Jan; 127(1):137-58. PubMed ID: 19782744 [TBL] [Abstract][Full Text] [Related]
13. THE PREVALENCE OF ONYCHOMYCOSIS IN THE ZAGREB AREA - THE ROLE OF SABOURAUD AGAR WITHOUT CYCLOHEXIMIDE IN DIAGNOSIS AND THERAPY. Mendek S; Lugović-Mihić L; Ferček I; Japundžić I; Šitum M; Abram M Acta Clin Croat; 2018 Dec; 57(4):726-735. PubMed ID: 31168210 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin. Wildfeuer A; Seidl HP; Paule I; Haberreiter A Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984 [TBL] [Abstract][Full Text] [Related]
15. A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro. Shadomy S; Dixon DM; May R Sabouraudia; 1982 Dec; 20(4):313-23. PubMed ID: 7157107 [TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Gupta AK; Kohli Y Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235 [TBL] [Abstract][Full Text] [Related]
17. [In vitro antifungal spectrum of ciclopiroxolamine]. Goudard M; Regli P; Lubrano N Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):621-3. PubMed ID: 2797886 [TBL] [Abstract][Full Text] [Related]
18. Species distribution and antifungal susceptibilities of dermatophytes during a one year period at a university hospital in Turkey. Ozkutuk A; Ergon C; Yulug N Mycoses; 2007 Mar; 50(2):125-9. PubMed ID: 17305776 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and antifungal susceptibility patterns of dermatophytes isolated from patients with neoplastic diseases: a case control study. Irimie M; Oanta A; Irimie CA; Minea DI Acta Dermatovenerol Croat; 2015; 23(2):108-13. PubMed ID: 26228822 [TBL] [Abstract][Full Text] [Related]
20. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Nenoff P; Haustein UF; Brandt W Skin Pharmacol; 1996; 9(6):388-94. PubMed ID: 9055360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]